| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABCB6 | ATP binding cassette subfamily B member 6 (Langereis blood group) |
10058 | Q9NP58 | chr2: 219,209,768-219,218,990 |
ACE | angiotensin I converting enzyme |
1636 | P12821 | chr17: 63,477,061-63,498,380 |
ACTB | actin, beta |
60 | P60709 | chr7: 5,527,151-5,563,784 |
ACVR1 | activin A receptor type I |
90 | Q04771 | chr2: 157,736,444-157,875,862 |
ACVR2A | activin A receptor type IIA |
92 | P27037 | chr2: 147,844,517-147,930,826 |
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif 7 |
11173 | Q9UKP4 | chr15: 78,759,203-78,811,431 |
ADARB1 | adenosine deaminase, RNA-specific, B1 |
104 | P78563 | chr21: 45,073,853-45,226,560 |
ADGRD2 | adhesion G protein-coupled receptor D2 |
347088 | Q7Z7M1 | chr9: 124,451,425-124,478,589 |
ADIPOQ | adiponectin, C1Q and collagen domain containing |
9370 | Q15848 | chr3: 186,842,690-186,858,463 |
ADIPOR1 | adiponectin receptor 1 |
51094 | Q96A54 | chr1: 202,940,823-202,958,572 |
ADIPOR2 | adiponectin receptor 2 |
79602 | Q86V24 | chr12: 1,688,574-1,788,678 |
ADRA1A | adrenoceptor alpha 1A |
148 | P35348 | chr8: 26,748,150-26,867,273 |
ADRA1B | adrenoceptor alpha 1B |
147 | P35368 | chr5: 159,865,080-159,972,544 |
ADRA1D | adrenoceptor alpha 1D |
146 | P25100 | chr20: 4,220,631-4,249,074 |
ADRA2B | adrenoceptor alpha 2B |
151 | P18089 | chr2: 96,112,875-96,116,245 |
ADRB2 | adrenoceptor beta 2 |
154 | P07550 | chr5: 148,825,245-148,828,687 |
ADRB3 | adrenoceptor beta 3 |
155 | P13945 | chr8: 37,962,991-37,966,965 |
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
183 | P01019 | chr1: 230,702,523-230,714,297 |
AGTR2 | angiotensin II receptor, type 2 |
186 | P50052 | chrX: 116,170,722-116,174,972 |
AGXT | alanine-glyoxylate aminotransferase |
189 | P21549 | chr2: 240,868,479-240,880,502 |
AKR1C1 | aldo-keto reductase family 1, member C1 |
1645 | Q04828 | chr10: 4,963,253-4,983,283 |
AKR1C2 | aldo-keto reductase family 1, member C2 |
1646 | P52895 | chr10: 4,987,400-5,018,031 |
AKR1C3 | aldo-keto reductase family 1, member C3 |
8644 | P42330 | chr10: 5,035,354-5,107,686 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
208 | P31751 | chr19: 40,230,317-40,285,536 |
ALB | albumin |
213 | P02768 | chr4: 73,397,114-73,421,412 |
AMH | anti-Mullerian hormone |
268 | P03971 | chr19: 2,249,309-2,252,073 |
AMHR2 | anti-Mullerian hormone receptor, type II |
269 | Q16671 | chr12: 53,423,855-53,431,534 |
ANKK1 | ankyrin repeat and kinase domain containing 1 |
255239 | Q8NFD2 | chr11: 113,387,791-113,400,418 |
ANLN | anillin actin binding protein |
54443 | Q9NQW6 | chr7: 36,389,806-36,453,791 |
AOPEP | aminopeptidase O |
84909 | Q8N6M6 | chr9: 94,726,701-95,087,218 |
APOA1 | apolipoprotein A-I |
335 | P02647 | chr11: 116,835,751-116,837,950 |
APOB | apolipoprotein B |
338 | P04114 | chr2: 21,001,429-21,044,073 |
APOE | apolipoprotein E |
348 | P02649 | chr19: 44,905,754-44,909,393 |
APRT | adenine phosphoribosyltransferase |
353 | P07741 | chr16: 88,809,339-88,811,944 |
AQP8 | aquaporin 8 |
343 | O94778 | chr16: 25,215,731-25,228,940 |
AQP9 | aquaporin 9 |
366 | O43315 | chr15: 58,138,169-58,185,911 |
AR | androgen receptor |
367 | P10275 | chrX: 67,544,032-67,730,619 |
ARHGAP23 | Rho GTPase activating protein 23 |
57636 | Q9P227 | chr17: 38,419,280-38,512,392 |
ARHGAP30 | Rho GTPase activating protein 30 |
257106 | Q7Z6I6 | chr1: 161,046,946-161,069,970 |
ARID1B | AT-rich interaction domain 1B |
57492 | Q8NFD5 | chr6: 156,777,374-157,210,779 |
ASPM | abnormal spindle microtubule assembly |
259266 | Q8IZT6 | chr1: 197,084,128-197,146,694 |
ATF1 | activating transcription factor 1 |
466 | P18846 | chr12: 50,763,710-50,821,122 |
ATN1 | atrophin 1 |
1822 | P54259 | chr12: 6,924,463-6,942,321 |
AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
563 | P25311 | chr7: 99,966,720-99,976,157 |
BAX | BCL2-associated X protein |
581 | Q07812 | chr19: 48,954,815-48,961,798 |
BBOF1 | basal body orientation factor 1 |
80127 | Q8ND07 | chr14: 74,019,353-74,082,863 |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) |
53335 | Q9H165 | chr2: 60,451,167-60,553,567 |
BCL2 | B-cell CLL/lymphoma 2 |
596 | P10415 | chr18: 63,123,346-63,320,128 |
BLOC1S3 | biogenesis of lysosomal organelles complex-1, subunit 3 |
388552 | Q6QNY0 | chr19: 45,178,745-45,181,801 |
BMP15 | bone morphogenetic protein 15 |
9210 | O95972 | chrX: 50,910,784-50,916,607 |
BMP4 | bone morphogenetic protein 4 |
652 | P12644 | chr14: 53,949,736-53,958,761 |
BMP6 | bone morphogenetic protein 6 |
654 | P22004 | chr6: 7,726,797-7,881,422 |
BRD2 | bromodomain containing 2 |
6046 | P25440 | chr6: 32,968,660-32,981,505 |
C12orf66 | chromosome 12 open reading frame 66 |
144577 | Q96MD2 | chr12: 64,186,316-64,222,296 |
C19orf68 | chromosome 19 open reading frame 68 |
374920 | Q86XI8 | chr19: 48,170,692-48,197,620 |
C1QTNF3 | C1q and tumor necrosis factor related protein 3 |
114899 | Q9BXJ4 | chr5: 34,019,448-34,043,832 |
C3 | complement component 3 |
718 | P01024 | chr19: 6,677,704-6,730,562 |
CAMK2D | calcium/calmodulin-dependent protein kinase II delta |
817 | Q13557 | chr4: 113,451,032-113,761,927 |
CAPN10 | calpain 10 |
11132 | Q9HC96 | chr2: 240,586,716-240,617,705 |
CAPN5 | calpain 5 |
726 | O15484 | chr11: 77,066,932-77,126,155 |
CCK | cholecystokinin |
885 | P06307 | chr3: 42,257,825-42,266,207 |
CCL2 | chemokine (C-C motif) ligand 2 |
6347 | P13500 | chr17: 34,255,218-34,257,203 |
CCL3 | chemokine (C-C motif) ligand 3 |
6348 | P10147 | chr17: 36,088,256-36,090,169 |
CCNB1 | cyclin B1 |
891 | P14635 | chr5: 69,167,010-69,178,245 |
CCND2 | cyclin D2 |
894 | P30279 | chr12: 4,273,772-4,305,350 |
CCNE2 | cyclin E2 |
9134 | O96020 | chr8: 94,879,770-94,896,678 |
CCNI | cyclin I |
10983 | Q14094 | chr4: 77,047,158-77,076,005 |
CD36 | CD36 molecule (thrombospondin receptor) |
948 | P16671 | chr7: 80,369,575-80,679,277 |
CD40LG | CD40 ligand |
959 | P29965 | chrX: 136,648,193-136,660,390 |
CD44 | CD44 molecule (Indian blood group) |
960 | P16070 | chr11: 35,138,870-35,232,402 |
CDC6 | cell division cycle 6 |
990 | Q99741 | chr17: 40,287,633-40,304,657 |
CDH15 | cadherin 15, type 1, M-cadherin (myotubule) |
1013 | P55291 | chr16: 89,171,767-89,195,492 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 | P38936 | chr6: 36,676,460-36,687,339 |
CEP55 | centrosomal protein 55kDa |
55165 | Q53EZ4 | chr10: 93,496,632-93,529,092 |
CFTR | cystic fibrosis transmembrane conductance regulator |
1080 | P13569 | chr7: 117,465,784-117,715,971 |
CGB5 | chorionic gonadotropin, beta polypeptide 5 |
93659 | P0DN86 | chr19: 49,043,884-49,045,311 |
CKS2 | CDC28 protein kinase regulatory subunit 2 |
1164 | P33552 | chr9: 89,311,198-89,316,703 |
CLDN4 | claudin 4 |
1364 | O14493 | chr7: 73,799,542-73,832,693 |
CMTR2 | cap methyltransferase 2 |
55783 | Q8IYT2 | chr16: 71,281,389-71,289,715 |
CNR1 | cannabinoid receptor 1 (brain) |
1268 | P21554 | chr6: 88,139,864-88,166,359 |
CNTROB | centrobin, centrosomal BRCA2 interacting protein |
116840 | Q8N137 | chr17: 7,932,101-7,949,918 |
COMT | catechol-O-methyltransferase |
1312 | P21964 | chr22: 19,941,607-19,969,975 |
CPB2 | carboxypeptidase B2 |
1361 | Q96IY4 | chr13: 46,053,186-46,105,076 |
CRP | C-reactive protein, pentraxin-related |
1401 | P02741 | chr1: 159,712,289-159,714,589 |
CYC1 | cytochrome c-1 |
1537 | P08574 | chr8: 144,095,027-144,097,525 |
CYP11A1 | cytochrome P450 family 11 subfamily A member 1 |
1583 | P05108 | chr15: 74,337,759-74,367,740 |
CYP11B2 | cytochrome P450 family 11 subfamily B member 2 |
1585 | P19099 | chr8: 142,910,559-142,917,843 |
CYP17A1 | cytochrome P450 family 17 subfamily A member 1 |
1586 | P05093 | chr10: 102,830,531-102,837,533 |
CYP19A1 | cytochrome P450 family 19 subfamily A member 1 |
1588 | P11511 | chr15: 51,208,057-51,338,610 |
CYP1A1 | cytochrome P450 family 1 subfamily A member 1 |
1543 | P04798 | chr15: 74,719,542-74,725,610 |
CYP21A2 | cytochrome P450 family 21 subfamily A member 2 |
1589 | P08686 | chr6: 32,038,265-32,041,670 |
CYP27B1 | cytochrome P450 family 27 subfamily B member 1 |
1594 | O15528 | chr12: 57,762,334-57,768,986 |
CYP2B6 | cytochrome P450 family 2 subfamily B member 6 |
1555 | P20813 | chr19: 40,991,299-41,018,398 |
CYP2C9 | cytochrome P450 family 2 subfamily C member 9 |
1559 | P11712 | chr10: 94,938,658-94,989,390 |
CYP2D6 | cytochrome P450 family 2 subfamily D member 6 |
1565 | P10635 | chr22: 42,126,499-42,130,906 |
CYP3A7 | CYP3A7-CYP3A51P readthrough |
1551 | P24462 | chr7: 99,705,037-99,735,196 |
CYR61 | cysteine-rich, angiogenic inducer, 61 |
3491 | O00622 | chr1: 85,580,761-85,583,962 |
DACT3 | dishevelled-binding antagonist of beta-catenin 3 |
147906 | Q96B18 | chr19: 46,647,612-46,661,138 |
DCBLD2 | discoidin, CUB and LCCL domain containing 2 |
131566 | Q96PD2 | chr3: 98,795,941-98,901,689 |
DDX54 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 |
79039 | Q8TDD1 | chr12: 113,157,174-113,185,479 |
DENND1A | DENN/MADD domain containing 1A |
57706 | Q8TEH3 | chr9: 123,379,654-123,930,152 |
DLG4 | discs, large homolog 4 (Drosophila) |
1742 | P78352 | chr17: 7,189,890-7,219,702 |
DLL4 | delta-like 4 (Drosophila) |
54567 | Q9NR61 | chr15: 40,929,340-40,939,072 |
DMD | dystrophin |
1756 | P11532 | chrX: 31,097,677-33,339,441 |
DUX4L5 | double homeobox 4 like 5 |
653545 | P0CJ88 | chr4: 190,077,818-190,079,092 |
EIF2B4 | eukaryotic translation initiation factor 2B subunit delta |
8890 | Q9UI10 | chr2: 27,364,352-27,370,486 |
ELAVL3 | ELAV like neuron-specific RNA binding protein 3 |
1995 | Q14576 | chr19: 11,451,326-11,481,046 |
EMSY | EMSY, BRCA2-interacting transcriptional repressor |
56946 | Q7Z589 | chr11: 76,444,923-76,553,025 |
ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 | P22413 | chr6: 131,808,016-131,895,155 |
EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) |
2052 | P07099 | chr1: 225,810,092-225,845,563 |
ERRFI1 | ERBB receptor feedback inhibitor 1 |
54206 | Q9UJM3 | chr1: 8,004,404-8,026,308 |
ESR1 | estrogen receptor 1 |
2099 | P03372 | chr6: 151,656,691-152,129,619 |
ESR2 | estrogen receptor 2 (ER beta) |
2100 | Q92731 | chr14: 64,084,232-64,338,112 |
F2 | coagulation factor II (thrombin) |
2147 | P00734 | chr11: 46,719,180-46,739,506 |
F5 | coagulation factor V (proaccelerin, labile factor) |
2153 | P12259 | chr1: 169,514,166-169,586,588 |
FABP4 | fatty acid binding protein 4, adipocyte |
2167 | P15090 | chr8: 81,478,419-81,483,263 |
FAM84A | family with sequence similarity 84 member A |
151354 | Q96KN4 | chr2: 14,632,686-14,650,814 |
FAS | Fas cell surface death receptor |
355 | P25445 | chr10: 88,990,582-89,015,785 |
FAT1 | FAT atypical cadherin 1 |
2195 | Q14517 | chr4: 186,587,783-186,726,722 |
FBN3 | fibrillin 3 |
84467 | Q75N90 | chr19: 8,065,402-8,149,846 |
FBXO44 | F-box protein 44 |
93611 | Q9H4M3 | chr1: 11,654,375-11,663,327 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 | P12314 | chr1: 149,782,671-149,792,518 |
FCGR1CP | Fc fragment of IgG receptor Ic, pseudogene |
100132417 | A6NKC4 | chr1: 143,874,793-143,883,575 |
FEM1A | fem-1 homolog a (C. elegans) |
55527 | Q9BSK4 | chr19: 4,791,681-4,801,273 |
FEM1B | fem-1 homolog b (C. elegans) |
10116 | Q9UK73 | chr15: 68,277,803-68,295,865 |
FEM1C | fem-1 homolog c (C. elegans) |
56929 | Q96JP0 | chr5: 115,520,908-115,544,894 |
FGF18 | fibroblast growth factor 18 |
8817 | O76093 | chr5: 171,419,656-171,457,623 |
FGF19 | fibroblast growth factor 19 |
9965 | O95750 | chr11: 69,698,232-69,704,642 |
FGFR1 | fibroblast growth factor receptor 1 |
2260 | P11362 | chr8: 38,411,138-38,468,834 |
FLT4 | fms-related tyrosine kinase 4 |
2324 | P35916 | chr5: 180,601,506-180,649,624 |
FMR1 | fragile X mental retardation 1 |
2332 | Q06787 | chrX: 147,911,951-147,951,125 |
FOS | FBJ murine osteosarcoma viral oncogene homolog |
2353 | P01100 | chr14: 75,278,774-75,282,230 |
FOXO1 | forkhead box O1 |
2308 | Q12778 | chr13: 40,469,953-40,666,597 |
FOXP3 | forkhead box P3 |
50943 | Q9BZS1 | chrX: 49,250,436-49,264,826 |
FRAXA | fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) |
2477 | N/A | chrX |
FSBP | fibrinogen silencer binding protein |
100861412 | O95073 | chr8: 94,372,170-94,436,952 |
FSHB | follicle stimulating hormone, beta polypeptide |
2488 | P01225 | chr11: 30,231,016-30,235,261 |
FSHR | follicle stimulating hormone receptor |
2492 | P23945 | chr2: 48,962,157-49,154,537 |
FST | follistatin |
10468 | P19883 | chr5: 53,480,409-53,487,134 |
FTO | fat mass and obesity associated |
79068 | Q9C0B1 | chr16: 53,701,692-54,158,512 |
FUT7 | fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
2529 | Q11130 | chr9: 137,030,174-137,033,010 |
G6PC | glucose-6-phosphatase, catalytic subunit |
2538 | P35575 | chr17: 42,900,797-42,913,369 |
GAB1 | GRB2 associated binding protein 1 |
2549 | Q13480 | chr4: 143,336,762-143,474,568 |
GATA6 | GATA binding protein 6 |
2627 | Q92908 | chr18: 22,169,443-22,202,528 |
GCNT2 | glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
2651 | Q8N0V5 | chr6: 10,492,223-10,629,368 |
GDF9 | growth differentiation factor 9 |
2661 | O60383 | chr5: 132,861,181-132,866,884 |
GH1 | growth hormone 1 |
2688 | P01241 | chr17: 63,917,200-63,918,838 |
GHRH | growth hormone releasing hormone |
2691 | P01286 | chr20: 37,251,082-37,261,835 |
GHRL | ghrelin/obestatin prepropeptide |
51738 | Q9UBU3 | chr3: 10,285,675-10,292,947 |
GLTSCR2 | glioma tumor suppressor candidate region gene 2 |
29997 | Q9NZM5 | chr19: 47,745,522-47,757,058 |
GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
2776 | P50148 | chr9: 77,716,087-78,031,458 |
GNAS | GNAS complex locus |
2778 | O95467 | chr20: 58,839,718-58,911,192 |
GNAS | GNAS complex locus |
2778 | P63092 | chr20: 58,839,718-58,911,192 |
GNAS | GNAS complex locus |
2778 | P84996 | chr20: 58,839,718-58,911,192 |
GNAS | GNAS complex locus |
2778 | Q5JWF2 | chr20: 58,839,718-58,911,192 |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 |
2784 | P16520 | chr12: 6,839,954-6,847,393 |
GNRH1 | gonadotropin releasing hormone 1 |
2796 | P01148 | chr8: 25,419,260-25,424,654 |
GNRHR | gonadotropin releasing hormone receptor |
2798 | P30968 | chr4: 67,739,328-67,754,360 |
GOT2 | glutamic-oxaloacetic transaminase 2 |
2806 | P00505 | chr16: 58,707,131-58,734,357 |
GP1BB | glycoprotein Ib (platelet), beta polypeptide |
2812 | P13224 | chr22: 19,722,945-19,724,771 |
GREB1 | growth regulation by estrogen in breast cancer 1 |
9687 | Q4ZG55 | chr2: 11,482,341-11,642,788 |
GSK3B | glycogen synthase kinase 3 beta |
2932 | P49841 | chr3: 119,821,323-120,094,417 |
GSTM1 | glutathione S-transferase mu 1 |
2944 | P09488 | chr1: 109,687,814-109,709,039 |
GSTT1 | glutathione S-transferase theta 1 |
2952 | P30711 | chr22: 24,033,952-24,042,493 |
GYS2 | glycogen synthase 2 |
2998 | P54840 | chr12: 21,536,189-21,604,847 |
H6PD | hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
9563 | O95479 | chr1: 9,234,775-9,271,337 |
HACD1 | 3-hydroxyacyl-CoA dehydratase 1 |
9200 | B0YJ81 | chr10: 17,589,032-17,617,377 |
HAMP | hepcidin antimicrobial peptide |
57817 | P81172 | chr19: 35,280,716-35,285,143 |
HDAC3 | histone deacetylase 3 |
8841 | O15379 | chr5: 141,620,876-141,636,870 |
HELLS | helicase, lymphoid-specific |
3070 | Q9NRZ9 | chr10: 94,501,434-94,613,905 |
HHEX | hematopoietically expressed homeobox |
3087 | Q03014 | chr10: 92,689,951-92,695,646 |
HLA-A | major histocompatibility complex, class I, A |
3105 | P30443 | chr6: 29,941,260-29,945,884 |
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
3123 | P04229 | chr6: 32,578,769-32,589,848 |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
3126 | P13762 | chr6: 32,542,598-32,557,561 |
HMGA2 | high mobility group AT-hook 2 |
8091 | P52926 | chr12: 65,824,131-65,966,295 |
HMGB1 | high mobility group box 1 |
3146 | P09429 | chr13: 30,456,704-30,617,597 |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase |
3156 | P04035 | chr5: 75,336,329-75,362,104 |
HMMR | hyaluronan-mediated motility receptor (RHAMM) |
3161 | O75330 | chr5: 163,460,203-163,491,945 |
HOOK3 | hook microtubule-tethering protein 3 |
84376 | Q86VS8 | chr8: 42,896,932-43,030,539 |
HOXA10 | homeobox A10 |
3206 | P31260 | chr7: 27,170,591-27,180,261 |
HP | haptoglobin |
3240 | P00738 | chr16: 72,054,592-72,061,055 |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
3290 | P28845 | chr1: 209,686,178-209,734,950 |
HSD17B1 | hydroxysteroid (17-beta) dehydrogenase 1 |
3292 | P14061 | chr17: 42,549,214-42,555,213 |
HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 |
3294 | P37059 | chr16: 82,035,004-82,098,534 |
HSD17B6 | hydroxysteroid (17-beta) dehydrogenase 6 |
8630 | O14756 | chr12: 56,752,161-56,787,790 |
HSD17B7 | hydroxysteroid (17-beta) dehydrogenase 7 |
51478 | P56937 | chr1: 162,790,702-162,812,817 |
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
3283 | P14060 | chr1: 119,507,198-119,515,054 |
HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
3284 | P26439 | chr1: 119,414,931-119,423,035 |
HSP90AA1 | heat shock protein 90kDa alpha family class A member 1 |
3320 | P07900 | chr14: 102,080,738-102,139,699 |
HSPA1A | heat shock protein family A (Hsp70) member 1A |
3303 | P0DMV8 | chr6: 31,815,464-31,817,946 |
HSPB1 | heat shock protein family B (small) member 1 |
3315 | P04792 | chr7: 76,302,544-76,304,295 |
HSPB2 | heat shock protein family B (small) member 2 |
3316 | Q16082 | chr11: 111,912,242-111,914,093 |
HSPB3 | heat shock protein family B (small) member 3 |
8988 | Q12988 | chr5: 54,455,601-54,456,384 |
IDE | insulin-degrading enzyme |
3416 | P14735 | chr10: 92,451,684-92,574,076 |
IGF1 | insulin like growth factor 1 |
3479 | P05019 | chr12: 102,395,867-102,480,645 |
IGF1R | insulin like growth factor 1 receptor |
3480 | P08069 | chr15: 98,648,971-98,964,530 |
IGF2 | insulin like growth factor 2 |
3481 | P01344 | chr11: 2,129,112-2,141,238 |
IGF2R | insulin like growth factor 2 receptor |
3482 | P11717 | chr6: 159,969,099-160,113,507 |
IGFBP1 | insulin like growth factor binding protein 1 |
3484 | P08833 | chr7: 45,888,357-45,893,668 |
IGHG1 | immunoglobulin heavy constant gamma 1 (G1m marker) |
3500 | P01857 | chr14: 105,736,343-105,743,071 |
IL10 | interleukin 10 |
3586 | P22301 | chr1: 206,767,602-206,772,494 |
IL18 | interleukin 18 |
3606 | Q14116 | chr11: 112,143,251-112,164,117 |
IL1A | interleukin 1 alpha |
3552 | P01583 | chr2: 112,773,915-112,784,590 |
IL1B | interleukin 1 beta |
3553 | P01584 | chr2: 112,829,751-112,836,903 |
IL1R1 | interleukin 1 receptor, type I |
3554 | P14778 | chr2: 102,064,544-102,179,874 |
IL1RN | interleukin 1 receptor antagonist |
3557 | P18510 | chr2: 113,107,214-113,134,016 |
IL34 | interleukin 34 |
146433 | Q6ZMJ4 | chr16: 70,579,895-70,660,682 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
INHA | inhibin alpha |
3623 | P05111 | chr2: 219,569,162-219,575,713 |
INHBA | inhibin beta A |
3624 | P08476 | chr7: 41,667,168-41,705,834 |
INHBB | inhibin beta B |
3625 | P09529 | chr2: 120,346,143-120,351,808 |
INS | insulin |
3630 | P01308 | chr11: 2,159,779-2,161,341 |
INSL3 | insulin like 3 |
3640 | P51460 | chr19: 17,816,512-17,821,574 |
INSR | insulin receptor |
3643 | P06213 | chr19: 7,112,255-7,294,034 |
IQCC | IQ motif containing C |
55721 | Q4KMZ1 | chr1: 32,205,661-32,208,687 |
IRS1 | insulin receptor substrate 1 |
3667 | P35568 | chr2: 226,731,317-226,799,759 |
IRS2 | insulin receptor substrate 2 |
8660 | Q9Y4H2 | chr13: 109,752,698-109,786,568 |
ISYNA1 | inositol-3-phosphate synthase 1 |
51477 | Q9NPH2 | chr19: 18,434,388-18,438,301 |
ITGAX | integrin subunit alpha X |
3687 | P20702 | chr16: 31,355,134-31,382,997 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
ITLN1 | intelectin 1 (galactofuranose binding) |
55600 | Q8WWA0 | chr1: 160,876,539-160,885,170 |
JSRP1 | junctional sarcoplasmic reticulum protein 1 |
126306 | Q96MG2 | chr19: 2,252,252-2,269,759 |
KCNJ11 | potassium channel, inwardly rectifying subfamily J, member 11 |
3767 | Q14654 | chr11: 17,385,859-17,389,331 |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 |
10656 | O75525 | chr8: 135,457,457-135,656,722 |
KISS1 | KiSS-1 metastasis-suppressor |
3814 | Q15726 | chr1: 204,190,341-204,196,486 |
KITLG | KIT ligand |
4254 | P21583 | chr12: 88,492,793-88,580,851 |
KLK3 | kallikrein related peptidase 3 |
354 | P07288 | chr19: 50,854,915-50,860,764 |
KRT3 | keratin 3, type II |
3850 | P12035 | chr12: 52,789,685-52,796,117 |
LARP4 | La ribonucleoprotein domain family member 4 |
113251 | Q71RC2 | chr12: 50,392,383-50,480,004 |
LATS1 | large tumor suppressor kinase 1 |
9113 | O95835 | chr6: 149,658,153-149,718,256 |
LEP | leptin |
3952 | P41159 | chr7: 128,241,284-128,257,628 |
LEPR | leptin receptor |
3953 | P48357 | chr1: 65,420,652-65,641,559 |
LHB | luteinizing hormone beta polypeptide |
3972 | P01229 | chr19: 49,015,980-49,017,081 |
LHCGR | luteinizing hormone/choriogonadotropin receptor |
3973 | P22888 | chr2: 48,686,775-48,755,730 |
LIF | leukemia inhibitory factor |
3976 | P15018 | chr22: 30,240,447-30,246,851 |
LIFR | leukemia inhibitory factor receptor alpha |
3977 | P42702 | chr5: 38,474,963-38,608,354 |
LINC00475 | long intergenic non-protein coding RNA 475 |
158314 | N/A | chr9: 92,141,298-92,160,114 |
LIPE | lipase, hormone-sensitive |
3991 | Q05469 | chr19: 42,401,507-42,427,426 |
LMNA | lamin A/C |
4000 | P02545 | chr1: 156,082,573-156,140,089 |
LPCAT2 | lysophosphatidylcholine acyltransferase 2 |
54947 | Q7L5N7 | chr16: 55,508,998-55,586,670 |
LPIN1 | lipin 1 |
23175 | Q14693 | chr2: 11,677,595-11,827,409 |
LPP | LIM domain containing preferred translocation partner in lipoma |
4026 | Q93052 | chr3: 188,153,284-188,890,671 |
LRP5 | LDL receptor related protein 5 |
4041 | O75197 | chr11: 68,312,609-68,449,275 |
LRRC16B | leucine rich repeat containing 16B |
90668 | Q8ND23 | chr14: 24,052,000-24,069,728 |
LSM5 | LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
23658 | Q9Y4Y9 | chr7: 32,485,332-32,495,283 |
LTK | leukocyte receptor tyrosine kinase |
4058 | P29376 | chr15: 41,503,638-41,513,887 |
MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) |
4085 | Q13257 | chr4: 120,055,608-120,067,074 |
MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 |
378938 | Q9UHZ2 | chr11: 65,502,914-65,503,008 |
MANEA | mannosidase, endo-alpha |
79694 | Q5SRI9 | chr6: 95,577,543-95,609,457 |
MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 |
23162 | Q9UPT6 | chr16: 1,706,183-1,770,317 |
MAPRE3 | microtubule associated protein RP/EB family member 3 |
22924 | Q9UPY8 | chr2: 26,970,612-27,027,196 |
MC4R | melanocortin 4 receptor |
4160 | P32245 | chr18: 60,371,110-60,372,775 |
MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 |
23101 | Q86YR7 | chr3: 183,178,043-183,428,778 |
MCM2 | minichromosome maintenance complex component 2 |
4171 | P49736 | chr3: 127,598,223-127,622,436 |
MCM7 | minichromosome maintenance complex component 7 |
4176 | P33993 | chr7: 100,092,728-100,101,940 |
MEF2A | myocyte enhancer factor 2A |
4205 | Q02078 | chr15: 99,565,417-99,716,466 |
MGAT5B | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B |
146664 | Q3V5L5 | chr17: 76,868,456-76,950,393 |
MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
4282 | P14174 | chr22: 23,894,004-23,895,227 |
MIR132 | microRNA 132 |
406921 | N/A | chr17: 2,049,908-2,050,008 |
MIR155 | microRNA 155 |
406947 | N/A | chr21: 25,573,980-25,574,044 |
MIR21 | microRNA 21 |
406991 | N/A | chr17: 59,841,266-59,841,337 |
MIR25 | microRNA 25 |
407014 | N/A | chr7: 100,093,560-100,093,643 |
MIR93 | microRNA 93 |
407050 | N/A | chr7: 100,093,768-100,093,847 |
MMP1 | matrix metallopeptidase 1 |
4312 | P03956 | chr11: 102,789,920-102,798,160 |
MMP2 | matrix metallopeptidase 2 |
4313 | P08253 | chr16: 55,389,700-55,506,691 |
MMP26 | matrix metallopeptidase 26 |
56547 | Q9NRE1 | chr11: 4,704,927-4,992,429 |
MMP9 | matrix metallopeptidase 9 |
4318 | P14780 | chr20: 46,008,908-46,016,561 |
MORN1 | MORN repeat containing 1 |
79906 | Q5T089 | chr1: 2,321,253-2,391,707 |
MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
4524 | P42898 | chr1: 11,785,723-11,806,920 |
MTNR1B | melatonin receptor 1B |
4544 | P49286 | chr11: 92,969,720-92,985,066 |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase |
4548 | Q99707 | chr1: 236,795,281-236,903,981 |
MUC1 | mucin 1, cell surface associated |
4582 | P15941 | chr1: 155,185,824-155,192,916 |
MUC5AC | mucin 5AC, oligomeric mucus/gel-forming |
4586 | P98088 | chr11: 1,157,953-1,201,138 |
MYBL1 | v-myb avian myeloblastosis viral oncogene homolog-like 1 |
4603 | P10243 | chr8: 66,562,175-66,614,247 |
NBN | nibrin |
4683 | O60934 | chr8: 89,933,336-90,003,228 |
NCOA3 | nuclear receptor coactivator 3 |
8202 | Q9Y6Q9 | chr20: 47,501,902-47,656,877 |
NCOR1 | nuclear receptor corepressor 1 |
9611 | O75376 | chr17: 16,029,157-16,218,185 |
NFIC | nuclear factor I/C (CCAAT-binding transcription factor) |
4782 | P08651 | chr19: 3,314,403-3,469,217 |
NGF | nerve growth factor (beta polypeptide) |
4803 | P01138 | chr1: 115,285,918-115,338,236 |
NGFR | nerve growth factor receptor |
4804 | P08138 | chr17: 49,495,293-49,515,017 |
NKX2-1 | NK2 homeobox 1 |
7080 | P43699 | chr14: 36,516,392-36,521,149 |
NMNAT3 | nicotinamide nucleotide adenylyltransferase 3 |
349565 | Q96T66 | chr3: 139,560,180-139,678,017 |
NOS3 | nitric oxide synthase 3 |
4846 | P29474 | chr7: 150,990,995-151,014,588 |
NPB | neuropeptide B |
256933 | Q8NG41 | chr17: 81,900,745-81,902,905 |
NPPB | natriuretic peptide B |
4879 | P16860 | chr1: 11,857,464-11,858,931 |
NR1H3 | nuclear receptor subfamily 1 group H member 3 |
10062 | Q13133 | chr11: 47,248,300-47,269,032 |
NR3C1 | nuclear receptor subfamily 3 group C member 1 |
2908 | P04150 | chr5: 143,277,931-143,435,512 |
NRG1 | neuregulin 1 |
3084 | Q02297 | chr8: 31,639,386-32,767,959 |
ODF3B | outer dense fiber of sperm tails 3B |
440836 | A8MYP8 | chr22: 50,529,710-50,532,580 |
OR2H4P | olfactory receptor family 2 subfamily H member 4 pseudogene |
442189 | N/A | chr6 |
PAEP | progestagen-associated endometrial protein |
5047 | P09466 | chr9: 135,561,756-135,566,955 |
PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 |
5063 | O75914 | chrX: 110,944,285-111,227,361 |
PAPPA | pregnancy-associated plasma protein A, pappalysin 1 |
5069 | Q13219 | chr9: 116,153,804-116,402,322 |
PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
9060 | O95340 | chr10: 87,659,613-87,747,705 |
PBK | PDZ binding kinase |
55872 | Q96KB5 | chr8: 27,809,620-27,838,095 |
PCDHA4 | protocadherin alpha 4 |
56144 | Q9UN74 | chr5: 140,806,929-141,012,344 |
PCDHA@ | protocadherin alpha cluster, complex locus |
56117 | N/A | chr5: 140,786,136-141,012,344 |
PCNA | proliferating cell nuclear antigen |
5111 | P12004 | chr20: 5,114,953-5,126,626 |
PCOS1 | polycystic ovary syndrome 1 |
5120 | N/A | chr19 |
PCSK1 | proprotein convertase subtilisin/kexin type 1 |
5122 | P29120 | chr5: 96,390,415-96,434,143 |
PDE3B | phosphodiesterase 3B |
5140 | Q13370 | chr11: 14,643,723-14,872,044 |
PDE8A | phosphodiesterase 8A |
5151 | O60658 | chr15: 84,980,440-85,139,145 |
PDLIM4 | PDZ and LIM domain 4 |
8572 | P50479 | chr5: 132,257,671-132,273,454 |
PEA15 | phosphoprotein enriched in astrocytes 15 |
8682 | Q15121 | chr1: 160,205,337-160,215,376 |
PGR | progesterone receptor |
5241 | P06401 | chr11: 101,029,624-101,130,524 |
PIGU | phosphatidylinositol glycan anchor biosynthesis class U |
128869 | Q9H490 | chr20: 34,560,542-34,698,790 |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 | P42336 | chr3: 179,148,114-179,240,093 |
PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 | P42338 | chr3: 138,652,699-138,834,938 |
PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 | O00329 | chr1: 9,651,732-9,729,114 |
PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
5294 | P48736 | chr7: 106,865,278-106,907,145 |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
5295 | P27986 | chr5: 68,215,720-68,301,821 |
PLA2G7 | phospholipase A2 group VII |
7941 | Q13093 | chr6: 46,704,201-46,735,693 |
PLAT | plasminogen activator, tissue |
5327 | P00750 | chr8: 42,175,233-42,207,724 |
PLAU | plasminogen activator, urokinase |
5328 | P00749 | chr10: 73,909,177-73,917,497 |
PLAUR | plasminogen activator, urokinase receptor |
5329 | Q03405 | chr19: 43,646,095-43,670,547 |
PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 |
57449 | O94827 | chr1: 6,466,092-6,520,061 |
PLG | plasminogen |
5340 | P00747 | chr6: 160,702,238-160,753,315 |
PLIN1 | perilipin 1 |
5346 | O60240 | chr15: 89,664,365-89,679,427 |
PNPLA2 | patatin like phospholipase domain containing 2 |
57104 | Q96AD5 | chr11: 818,902-825,573 |
POLG | polymerase (DNA directed), gamma |
5428 | P54098 | chr15: 89,305,198-89,334,861 |
POMC | proopiomelanocortin |
5443 | P01189 | chr2: 25,160,853-25,168,903 |
PON1 | paraoxonase 1 |
5444 | P27169 | chr7: 95,297,676-95,324,707 |
POTEF | POTE ankyrin domain family member F |
728378 | A5A3E0 | chr2: 130,074,030-130,129,222 |
PPARA | peroxisome proliferator-activated receptor alpha |
5465 | Q07869 | chr22: 46,150,521-46,243,756 |
PPARD | peroxisome proliferator-activated receptor delta |
5467 | Q03181 | chr6: 35,342,558-35,428,191 |
PPARG | peroxisome proliferator-activated receptor gamma |
5468 | P37231 | chr3: 12,287,368-12,434,356 |
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
10891 | Q9UBK2 | chr4: 23,755,041-23,904,089 |
PPP1R3A | protein phosphatase 1 regulatory subunit 3A |
5506 | Q16821 | chr7: 113,876,777-114,075,920 |
PPP2R4 | protein phosphatase 2A regulatory subunit 4 |
5524 | Q15257 | chr9: 129,110,950-129,148,946 |
PRDX4 | peroxiredoxin 4 |
10549 | Q13162 | chrX: 23,664,262-23,686,399 |
PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
5563 | P54646 | chr1: 56,645,322-56,715,335 |
PRKAG3 | protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
53632 | Q9UGI9 | chr2: 218,822,383-218,832,086 |
PRKAR2B | protein kinase, cAMP-dependent, regulatory subunit type II beta |
5577 | P31323 | chr7: 107,044,649-107,161,811 |
PRKD2 | protein kinase D2 |
25865 | Q9BZL6 | chr19: 46,674,275-46,717,127 |
PTAFR | platelet-activating factor receptor |
5724 | P25105 | chr1: 28,147,166-28,193,936 |
PTCRA | pre T-cell antigen receptor alpha |
171558 | Q6ISU1 | chr6: 42,915,989-42,925,835 |
PTGER3 | prostaglandin E receptor 3 |
5733 | P43115 | chr1: 70,852,353-71,047,808 |
PTH | parathyroid hormone |
5741 | P01270 | chr11: 13,492,055-13,496,181 |
PWWP2B | PWWP domain containing 2B |
170394 | Q6NUJ5 | chr10: 132,397,168-132,417,863 |
R3HCC1 | R3H domain and coiled-coil containing 1 |
203069 | Q9Y3T6 | chr8: 23,270,120-23,296,279 |
RAB2A | RAB2A, member RAS oncogene family |
5862 | P61019 | chr8: 60,516,857-60,623,627 |
RAB5B | RAB5B, member RAS oncogene family |
5869 | P61020 | chr12: 55,973,913-55,996,683 |
RACGAP1 | Rac GTPase activating protein 1 |
29127 | Q9H0H5 | chr12: 49,976,923-50,033,136 |
RAD54B | RAD54 homolog B (S. cerevisiae) |
25788 | Q9Y620 | chr8: 94,372,170-94,436,952 |
RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 |
5919 | Q99969 | chr7: 150,338,317-150,341,674 |
RASL10B | RAS-like family 10 member B |
91608 | Q96S79 | chr17: 35,731,649-35,743,521 |
RBM45 | RNA binding motif protein 45 |
129831 | Q8IUH3 | chr2: 178,112,424-178,139,011 |
RBP4 | retinol binding protein 4 |
5950 | P02753 | chr10: 93,591,687-93,601,744 |
RETN | resistin |
56729 | Q9HD89 | chr19: 7,669,044-7,670,454 |
REXO1 | REX1, RNA exonuclease 1 homolog |
57455 | Q8N1G1 | chr19: 1,815,246-1,848,463 |
RHPN1 | rhophilin, Rho GTPase binding protein 1 |
114822 | Q8TCX5 | chr8: 143,368,887-143,384,220 |
RP2 | retinitis pigmentosa 2 (X-linked recessive) |
6102 | O75695 | chrX: 46,836,940-46,882,358 |
RPL37A | ribosomal protein L37a |
6168 | P61513 | chr2: 216,498,189-216,579,180 |
RRM2 | ribonucleotide reductase M2 |
6241 | P31350 | chr2: 10,120,698-10,131,419 |
RUNX3 | runt-related transcription factor 3 |
864 | Q13761 | chr1: 24,899,511-24,965,121 |
S100A7A | S100 calcium binding protein A7A |
338324 | Q86SG5 | chr1: 153,416,524-153,423,225 |
S100A8 | S100 calcium binding protein A8 |
6279 | P05109 | chr1: 153,390,032-153,391,188 |
S100A9 | S100 calcium binding protein A9 |
6280 | P06702 | chr1: 153,357,854-153,361,027 |
S100P | S100 calcium binding protein P |
6286 | P25815 | chr4: 6,693,069-6,697,170 |
SAP30L | SAP30-like |
79685 | Q9HAJ7 | chr5: 154,445,957-154,461,054 |
SCNN1A | sodium channel, non voltage gated 1 alpha subunit |
6337 | P37088 | chr12: 6,346,843-6,377,730 |
SCT | secretin |
6343 | P09683 | chr11: 626,431-627,143 |
SERPINA12 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
145264 | Q8IW75 | chr14: 94,487,274-94,517,844 |
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 |
462 | P01008 | chr1: 173,903,804-173,917,378 |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 | P05121 | chr7: 101,127,089-101,139,266 |
SET | SET nuclear proto-oncogene |
6418 | Q01105 | chr9: 128,683,424-128,696,400 |
SFTPC | surfactant protein C |
6440 | P11686 | chr8: 22,156,913-22,164,479 |
SGTA | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
6449 | O43765 | chr19: 2,754,714-2,783,371 |
SHBG | sex hormone-binding globulin |
6462 | P04278 | chr17: 7,613,946-7,633,383 |
SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 |
6580 | O15245 | chr6: 160,121,789-160,158,718 |
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
6517 | P14672 | chr17: 7,281,667-7,288,257 |
SLC2A4RG | SLC2A4 regulator |
56731 | Q9NR83 | chr20: 63,739,861-63,743,505 |
SLC5A11 | solute carrier family 5 (sodium/inositol cotransporter), member 11 |
115584 | Q8WWX8 | chr16: 24,845,841-24,911,628 |
SLC5A3 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
6526 | P53794 | chr21: 34,073,570-34,106,262 |
SLPI | secretory leukocyte peptidase inhibitor |
6590 | P03973 | chr20: 45,252,239-45,254,564 |
SMAD4 | SMAD family member 4 |
4089 | Q13485 | chr18: 51,028,394-51,085,045 |
SMAD7 | SMAD family member 7 |
4092 | O15105 | chr18: 48,919,853-48,950,711 |
SOCS3 | suppressor of cytokine signaling 3 |
9021 | O14543 | chr17: 78,356,778-78,360,077 |
SORBS1 | sorbin and SH3 domain containing 1 |
10580 | Q9BX66 | chr10: 95,311,771-95,561,414 |
SOX15 | SRY-box 15 |
6665 | O60248 | chr17: 7,588,178-7,590,170 |
SPATA21 | spermatogenesis associated 21 |
374955 | Q7Z572 | chr1: 16,387,117-16,437,424 |
SPP1 | secreted phosphoprotein 1 |
6696 | P10451 | chr4: 87,975,650-87,983,426 |
SPTBN4 | spectrin, beta, non-erythrocytic 4 |
57731 | Q9H254 | chr19: 40,466,241-40,576,464 |
SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
6715 | P18405 | chr5: 6,633,343-6,674,386 |
SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
6716 | P31213 | chr2: 31,522,480-31,581,067 |
SREBF2 | sterol regulatory element binding transcription factor 2 |
6721 | Q12772 | chr22: 41,833,079-41,907,308 |
SRSF10 | serine/arginine-rich splicing factor 10 |
10772 | O75494 | chr1: 23,964,804-23,980,927 |
STAR | steroidogenic acute regulatory protein |
6770 | P49675 | chr8: 38,143,649-38,151,265 |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 | P40763 | chr17: 42,313,324-42,388,568 |
STK11 | serine/threonine kinase 11 |
6794 | Q15831 | chr19: 1,177,558-1,228,435 |
STON1 | stonin 1 |
286749 | Q9Y6Q2 | chr2: 48,529,925-48,776,517 |
STS | steroid sulfatase (microsomal), isozyme S |
412 | P08842 | chrX: 7,219,456-7,354,810 |
SULT2A1 | sulfotransferase family 2A member 1 |
6822 | Q06520 | chr19: 47,870,466-47,886,397 |
SUOX | sulfite oxidase |
6821 | P51687 | chr12: 55,997,180-56,006,641 |
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
10454 | Q15750 | chr22: 39,399,741-39,437,060 |
TBC1D4 | TBC1 domain family member 4 |
9882 | O60343 | chr13: 75,284,665-75,482,114 |
TBX1 | T-box 1 |
6899 | O43435 | chr22: 19,756,703-19,783,593 |
TCF15 | transcription factor 15 (basic helix-loop-helix) |
6939 | Q12870 | chr20: 603,797-610,398 |
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
6934 | Q9NQB0 | chr10: 112,950,250-113,167,678 |
TEAD2 | TEA domain family member 2 |
8463 | Q15562 | chr19: 49,340,595-49,362,457 |
TFRC | transferrin receptor |
7037 | P02786 | chr3: 196,027,183-196,082,189 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TH | tyrosine hydroxylase |
7054 | P07101 | chr11: 2,163,929-2,171,877 |
THADA | thyroid adenoma associated |
63892 | Q6YHU6 | chr2: 43,230,836-43,596,046 |
THAP3 | THAP domain containing, apoptosis associated protein 3 |
90326 | Q8WTV1 | chr1: 6,624,866-6,635,586 |
TIMP1 | TIMP metallopeptidase inhibitor 1 |
7076 | P01033 | chrX: 47,582,313-47,586,789 |
TM4SF4 | transmembrane 4 L six family member 4 |
7104 | P48230 | chr3: 149,473,974-149,503,281 |
TMEFF2 | transmembrane protein with EGF-like and two follistatin-like domains 2 |
23671 | Q9UIK5 | chr2: 191,949,043-192,195,709 |
TMEM151A | transmembrane protein 151A |
256472 | Q8N4L1 | chr11: 66,291,870-66,296,664 |
TMEM151B | transmembrane protein 151B |
441151 | Q8IW70 | chr6: 44,270,466-44,307,506 |
TMF1 | TATA element modulatory factor 1 |
7110 | P82094 | chr3: 69,019,827-69,052,303 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF1B | tumor necrosis factor receptor superfamily member 1B |
7133 | P20333 | chr1: 12,167,003-12,209,228 |
TNFSF10 | tumor necrosis factor superfamily member 10 |
8743 | P50591 | chr3: 172,505,508-172,523,507 |
TNPO2 | transportin 2 |
30000 | O14787 | chr19: 12,699,194-12,724,011 |
TNRC6B | trinucleotide repeat containing 6B |
23112 | Q9UPQ9 | chr22: 40,044,817-40,335,808 |
TONSL | tonsoku-like, DNA repair protein |
4796 | Q96HA7 | chr8: 144,428,775-144,444,444 |
TOP1 | topoisomerase (DNA) I |
7150 | P11387 | chr20: 41,028,818-41,124,487 |
TOP2A | topoisomerase (DNA) II alpha |
7153 | P11388 | chr17: 40,388,516-40,417,950 |
TOX3 | TOX high mobility group box family member 3 |
27324 | O15405 | chr16: 52,438,005-52,547,802 |
TRPV6 | transient receptor potential cation channel, subfamily V, member 6 |
55503 | Q9H1D0 | chr7: 142,871,203-142,885,762 |
TTK | TTK protein kinase |
7272 | P33981 | chr6: 80,003,887-80,042,527 |
TTLL9 | tubulin tyrosine ligase like 9 |
164395 | Q3SXZ7 | chr20: 31,870,702-31,944,963 |
TXNRD1 | thioredoxin reductase 1 |
7296 | Q16881 | chr12: 104,215,779-104,350,305 |
UBE2H | ubiquitin conjugating enzyme E2H |
7328 | P62256 | chr7: 129,830,732-129,952,949 |
UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) |
7351 | P55851 | chr11: 73,974,667-73,983,307 |
UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 |
7363 | P06133 | chr4: 69,480,165-69,526,014 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor |
7421 | P11473 | chr12: 47,841,537-47,943,048 |
VEGFA | vascular endothelial growth factor A |
7422 | P15692 | chr6: 43,770,184-43,786,487 |
WNT5A | wingless-type MMTV integration site family member 5A |
7474 | P41221 | chr3: 55,465,715-55,490,539 |
YAP1 | Yes associated protein 1 |
10413 | P46937 | chr11: 102,110,461-102,233,423 |
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
7534 | P63104 | chr8: 100,916,525-100,953,388 |
ZMYM5 | zinc finger, MYM-type 5 |
9205 | Q9UJ78 | chr13: 19,823,482-19,863,636 |
ZNF205 | zinc finger protein 205 |
7755 | O95201 | chr16: 3,112,560-3,120,517 |
ZNF430 | zinc finger protein 430 |
80264 | Q9H8G1 | chr19: 21,020,620-21,060,050 |